{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:36:09Z","timestamp":1792708569548,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.nbd.2023.106182","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T15:55:19Z","timestamp":1685980519000},"page":"106182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease"],"prefix":"10.1016","volume":"183","author":[{"given":"Lucia","family":"Batzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel J.","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Ver\u00e9b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106182_bb0005","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/archneurol.2009.267","article-title":"Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease","volume":"66","author":"Alcalay","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0010","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","article-title":"Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study","volume":"78","author":"Alcalay","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106182_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.parkreldis.2014.09.033","article-title":"Neuropsychological performance in LRRK2 G2019S carriers with Parkinson\u2019s disease","volume":"21","author":"Alcalay","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0020","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2023.106182_bb0025","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.06.025","article-title":"Head size, age and gender adjustment in MRI studies: a necessary nuisance?","volume":"53","author":"Barnes","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2023.106182_bb0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s10548-011-0195-9","article-title":"Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological aging","volume":"24","author":"Bartr\u00e9s-Faz","year":"2011","journal-title":"Brain Topogr."},{"key":"10.1016\/j.nbd.2023.106182_bb0035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/mds.27431","article-title":"Movement disorder society criteria for clinically established early Parkinson\u2019s disease","volume":"33","author":"Berg","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1474-4422(18)30073-5","article-title":"Hypercholinergic activity in LRRK2 Parkinson\u2019s disease","volume":"17","author":"Bohnen","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0045","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/jcbfm.2012.60","article-title":"Heterogeneity of cholinergic denervation in Parkinson\u2019s disease without dementia","volume":"32","author":"Bohnen","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2023.106182_bb0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0055","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2010.11.015","article-title":"Volumetric analysis of the substantia innominata in patients with Parkinson\u2019s disease according to cognitive status","volume":"33","author":"Choi","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2023.106182_bb0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.parkreldis.2014.04.016","article-title":"LRRK2 mutations in Parkinson\u2019s disease: confirmation of a gender effect in the Italian population","volume":"20","author":"Cilia","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","article-title":"Worldwide frequency of G2019S LRRK2 mutation in Parkinson\u2019s disease: a systematic review","volume":"16","author":"Correia Guedes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcmd.2006.02.004","article-title":"Increased incidence of Parkinson disease among relatives of patients with Gaucher disease","volume":"36","author":"Halperin","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.nbd.2023.106182_bb0080","series-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach","author":"Hayes","year":"2013"},{"key":"10.1016\/j.nbd.2023.106182_bb0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2013.08.010","article-title":"Cognitive reserve in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"20","author":"Hindle","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JAD-132345","article-title":"Subregional basal forebrain atrophy in Alzheimer\u2019s disease: a multicenter study","volume":"40","author":"Kilimann","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2023.106182_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(18)30032-2","article-title":"The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson\u2019s disease: a cross-sectional PET study","volume":"17","author":"Liu","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0105","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson\u2019s progression markers initiative (PPMI) - establishing a PD biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","article-title":"Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers","volume":"77","author":"Marras","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2023.106182_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mds.26061","article-title":"Clinical markers for identifying cholinergic deficits in Parkinson\u2019s disease","volume":"30","author":"Muller","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0120","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.nbd.2023.106182_bb0125","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/mds.28066","article-title":"A possible modifying effect of the G2019S mutation in the LRRK2 gene on GBA Parkinson\u2019s disease","volume":"35","author":"Omer","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5845","article-title":"Association of Dual LRRK2 G2019S and GBA variations with Parkinson disease progression","volume":"4","author":"Ortega","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.nbd.2023.106182_bb0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson Progression Marker Initiative (PPMI)","volume":"95","author":"Parkinson Progression Marker I","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2023.106182_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104831","article-title":"Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson\u2019s disease","volume":"139","author":"Pereira","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106182_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/brain\/awx310","article-title":"In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease","volume":"141","author":"Ray","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2023.106182_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.nbd.2023.106182_bb0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/brain\/awy072","article-title":"Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease","volume":"141","author":"Schulz","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2023.106182_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","article-title":"Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson\u2019s Progression Markers Initiative (PPMI): a cross-sectional study","volume":"19","author":"Simuni","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106182_bb0165","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.26161","article-title":"Cognitive profile of LRRK2-related Parkinson\u2019s disease","volume":"30","author":"Srivatsal","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106182_bb0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/1533317511424892","article-title":"Rivastigmine in Alzheimer\u2019s disease and Parkinson\u2019s disease dementia: an ADAS-cog factor analysis","volume":"26","author":"Weintraub","year":"2011","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"10.1016\/j.nbd.2023.106182_bb0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1474-4422(17)30056-X","article-title":"Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies","volume":"16","author":"Wile","year":"2017","journal-title":"Lancet Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:38:11Z","timestamp":1716377891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":35,"alternative-id":["S0969996123001973"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106182","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106182"}}